- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sofiva Genomics Co Ltd (6615)
Sofiva Genomics Co Ltd stock price live, this page displays TWO 6615 stock exchange data. View the 6615 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sofiva Genomics Co Ltd real time stock price chart below.
What Is the Sofiva Genomics Co Ltd Stock Price Today?
The Sofiva Genomics Co Ltd stock price today is 34.50.
What Is the Stock Symbol for Sofiva Genomics Co Ltd?
The stock ticker symbol for Sofiva Genomics Co Ltd is 6615.
Is 6615 the Same as $6615?
$6615 is a common way to refer to the Sofiva Genomics Co Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Sofiva Genomics Co Ltd Trade On?
Sofiva Genomics Co Ltd is listed and trades on the TPEX stock exchange.
Is Sofiva Genomics Co Ltd a Good Stock to Buy?
Determining whether Sofiva Genomics Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Sofiva Genomics Co Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6615 quote. (ISIN: TW0006615008)
What Is the Sofiva Genomics Co Ltd Stock Price Today?
The Sofiva Genomics Co Ltd stock price today is 34.50.
What Is the Stock Symbol for Sofiva Genomics Co Ltd?
The stock ticker symbol for Sofiva Genomics Co Ltd is 6615.
Is 6615 the Same as $6615?
$6615 is a common way to refer to the Sofiva Genomics Co Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Sofiva Genomics Co Ltd Trade On?
Sofiva Genomics Co Ltd is listed and trades on the TPEX stock exchange.
Is Sofiva Genomics Co Ltd a Good Stock to Buy?
Determining whether Sofiva Genomics Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Sofiva Genomics Co Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6615 quote. (ISIN: TW0006615008)
TPEX
Currency in TWD
34.50
0.00(0.00%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.45
34.90
52 wk Range
28.90
40.00
6615 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.4534.90
52 wk Range
28.9040.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6615 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Earnings
Latest Release
Aug 12, 2026
EPS / Forecast
0.25 / --
Revenue / Forecast
97.07M / --
Compare 6615 to Peers and Sector
Metrics to compare | 6615 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6615PeersSector | |
|---|---|---|---|---|
P/E Ratio | 52.4x | −47.8x | −0.4x | |
PEG Ratio | 0.18 | 10.09 | 0.00 | |
Price / Book | 1.1x | −97.2x | 2.6x | |
Price / LTM Sales | 2.0x | 18.3x | 3.1x | |
Upside (Analyst Target) | - | 20.3% | 47.7% | |
Fair Value Upside | Unlock | −33.7% | 6.5% | Unlock |
Sofiva Genomics Co.,Ltd. provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally. The company offers reproductive testing services, including preimplantation genetic testing for aneuploidy (PGT-A), non-invasive preimplantation genetic testing for aneuploidy (niPGT-A), and preimplantation genetic testing for monogenic diseases (PGT-M); and prenatal testing services, such as non-invasive prenatal screening, array, karyotyping, maternal serum screening for down syndrome, risk assessment for early/late-onset preeclampsia, folate metabolism genetic testing, congenital infection screening,carrier scan, thalassemia genetic testing, spinal muscular atrophy genetic testing, and fragile X syndrome genetic testing. It also provides baby genetic testing comprising sensorineural hearing loss genetic testing; congenital central hypoventilation syndrome genetic testing (CCHS); and congenital cytomegalovirus infection testing (CMV). In addition, the company offers cancer screening services, which includes human papillomavirus screening (HPV); and hereditary cancer testing services. Further, it develops precision medicine genetic testing; and offers testing services to patients and carriers with rare disorders. Sofiva Genomics Co.,Ltd. was founded in 2012 and is based in Taipei, Taiwan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Sofiva Genomics (6615) Stock Price Today?
The Sofiva Genomics stock price today is 34.50 TWD.
What Stock Exchange Does Sofiva Genomics Trade On?
Sofiva Genomics is listed and trades on the Taipei Exchange.
What Is the Stock Symbol for Sofiva Genomics?
The stock symbol for Sofiva Genomics is "6615."
What Is the Sofiva Genomics Market Cap?
As of today, Sofiva Genomics market cap is 744.97M TWD.
What Is Sofiva Genomics's Earnings Per Share (TTM)?
The Sofiva Genomics EPS (TTM) is 0.66.
When Is the Next Sofiva Genomics Earnings Date?
Sofiva Genomics will release its next earnings report on Nov 18, 2026.
From a Technical Analysis Perspective, Is 6615 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Sofiva Genomics Stock Split?
Sofiva Genomics has split 0 times.
What is the current trading status of Sofiva Genomics (6615)?
As of Aug 31, 2026, Sofiva Genomics (6615) is trading at a price of 34.50 TWD, with a previous close of 39.90 TWD. The stock has fluctuated within a day range of 34.45 TWD to 34.90 TWD, while its 52-week range spans from 28.90 TWD to 40.00 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.